The $583,000 four-year research award will aid research using monoclonal antibodies to lower the chances of non-Hodgkin lymphoma relapse, complications
May 14, 2012
The Fred Hutchinson Cancer Research Center's Dr. Andrew Rezvani has received a four-year, $583,000 mentored research scholar grant from the American Cancer Society. The award supports his work in improving outcomes for patients who receive blood and bone marrow transplants to treat non-Hodgkin lymphoma.
According to data compiled by the National Cancer Data Base, survival rates among patients treated for eight types of cancer top other programs accredited by Commission on Cancer
Feb. 21, 2012
| By Dean Forbes
Five-year survival rates among patients treated by Seattle Cancer Care Alliance for eight types of cancer are higher than for patients treated at the other cancer programs accredited by the Commission on Cancer of the American College of Surgeons. The National Cancer Data Base (NCDB), which is operated jointly by the commission with the American Cancer Society, compiled the survival rate data.
Dr. John Potter will receive honors and present an educational lecture on the successes and failures of chemoprevention during the 100th annual AACR meeting in Denver
April 20, 2009
| By Kristen Woodward
Cancer epidemiologist Dr. John Potter of the Fred Hutchinson Cancer Research Center's Public Health Sciences Division has been selected to receive the 18th Annual AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention.